Find Research Projects — HSC

1,500 - 1,511 out of 1,511 results

2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Research Project 2
Chaudhary, P.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Research Project 2
Chaudhary, P.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Research Project 1
Jones, H.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Research Project 1
Jones, H.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Core
Vishwanatha, J.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
Basha, R. & Prokai, L.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
Basha, R. & Prokai, L.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education
Vishwanatha, J.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education
Vishwanatha, J., Jones, H., Chaudhary, P., BASHA, R. M., VISHWANATHA, J., JONES, H. P., CHAUDHARY, P. & BASHA, R. M.
National Cancer Institute
1/09/18 → 31/08/21
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education
Vishwanatha, J., BASHA, R. M., JONES, H. P. & CHAUDHARY, P.
National Cancer Institute
20/09/18 → 31/08/22
Project: Research
¿A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study-Assess Safety/Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine-Administered Concomitantly with Routine Vaccines to Healthy Infants.
Fling, J.
GlaxoSmithKline
6/01/19 → 5/06/23
Project: Research